Zdrowie i gospodarka · 23/02/2016

FDA Extends Comment Period for Interoperable Medical Devices Draft Guidance

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on interoperable medical devices by 30 days, in response to industry requests, to allow more time for public feedback.